A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use

por Mills, Alexander, Myers, Laurie, Raudenbush, Casey, Vossen, David A., Teppler, Hedy, Miteva, Yanna R., Seeley, Suzanne, Homony, Brenda, Straus, Walter L.
Publicado 2021

1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study

por Teppler, Hedy, Shuldyakov, Andrey, Gankina, Natalia, Kulagin, Valeriy, Nagimova, Firaya, Shimonova, Tatiana, Sonin, Dmitriy, Sotnikov, Vladimir, Zakharova, Natalia, Homony, Brenda, Wang, Deng, Moshkovich, Grigoriy
Publicado 2014

Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK,...

por Cahn, Pedro, Sax, Paul E., Squires, Kathleen, Molina, Jean-Michel, Ratanasuwan, Winai, Rassool, Mohammed, Bloch, Mark, Xu, Xia, Zhou, Yan, Homony, Brenda, Hepler, Deborah, Teppler, Hedy, Hanna, George J., Nguyen, Bach-Yen, Greaves, Wayne
Publicado 2018